SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001494650-23-000037
Filing Date
2023-04-21
Accepted
2023-04-21 16:51:16
Documents
6
Period of Report
2023-04-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A optnprelimproxy2023.htm PRE 14A 749639
2 GRAPHIC capversusnetloss.jpg GRAPHIC 32860
3 GRAPHIC capversustotalshareholderr.jpg GRAPHIC 35449
4 GRAPHIC optinoseinc_prxyx2023jsnmo.jpg GRAPHIC 257750
5 GRAPHIC optinoseinc_prxyx2023jsnmoa.jpg GRAPHIC 196841
6 GRAPHIC optinoseinca05.jpg GRAPHIC 16040
  Complete submission text file 0001494650-23-000037.txt   1482189
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38241 | Film No.: 23836999
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences